|
"許駿"的相关文件
显示项目 1-25 / 145 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:33:37Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, S.-H. and Kuo, T.-C. and Wu, H. and Guo, J.-C. and Hsu, C. and Hsu, C.-H. and Tien, Y.-W. and Yeh, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;徐志宏;許駿;葉坤輝;郭哲銓;田郁文;郭庭均;楊士弘; Yang, Shih-Hung; TING-CHUN KUO; Yang, Shih-Hung; Yang, Shih-Hung; Kuo, Ting-Chun; Kuo, Ting-Chun; YU-WEN TIEN; Kuo, Ting-Chun; ANN-LII CHENG; Wu, Hsu; Guo, Jhe-Cyuan; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chiun; Hsu, Chih-Hung; Hsu, Chih-Hung; Tien, Yu-Wen; Tien, Yu-Wen; Tien, Yu-Wen; Yeh, Kun-Huei; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2018-09-10T15:18:35Z |
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
|
Hsu, Chiun;Chen, Bang-Bin;Chen, Chien-Hung;Ho, Ming-Chih;Cheng, Jason Chia-Hsien;Kokudo, Norihiro;Murakami, Takamichi;Yeo, Winnie;Seong, Jinsil;Jia, Ji-Dong;Han, Kwan-Hyub;Cheng, Ann-Lii; 鄭安理;成佳憲;陳邦斌;許駿;陳健弘;何明志; Hsu, Chiun; MING-CHIH HO; Hsu, Chiun; Chen, Bang-Bin; Chen, Bang-Bin; BANG-BIN CHEN; Wu, Chien-Te; Libertus, Melissa E.; ANN-LII CHENG; Chen, Chien-Hung; Chen, Chien-Hung; Meyerhoff, Karen L.; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Jason Chia-Hsien; Woldorff, Marty G.; Kokudo, Norihiro; Kokudo, Norihiro; Murakami, Takamichi; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Seong, Jinsil; Jia, Ji-Dong; Han, Kwan-Hyub; Cheng, Ann-Lii; 吳建德; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T15:01:52Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen, Bang-Bin;Shih, I-Lun;Wu, Chih-Horng;Hsu, Chiun;Chen, Chien-Hung;Shih, Tiffany Ting-Fang;Liu, Kao-Lang;Liang, Po-Chin; Chen, B.-B. and Shih, I.-L. and Wu, C.-H. and Hsu, C. and Chen, C.-H. and Shih, T.T.-F. and Liu, K.-L. and Liang, P.-C.; 吳志宏;施庭芳;陳邦斌;許駿;施怡倫;陳健弘;劉高郎;梁博欽; Chen, Bang-Bin; TIFFANY TING-FANG SHIH; Shih, I-Lun; CHIH-HORNG WU; Wu, Chih-Horng; PO-CHIN LIANG; KAO-LANG LIU; Hsu, Chiun; I-LUN SHIH; Chen, Chien-Hung; BANG-BIN CHEN; Shih, Tiffany Ting-Fang; Liu, Kao-Lang; Liang, Po-Chin |
| 臺大學術典藏 |
2018-09-10T14:58:12Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, D.-L. and Chang, C.-J. and Jeng, Y.-M. and Lin, Y.-J. and Lin, Z.-Z. and Gandhi, A.K. and Liao, S.-C. and Huang, Z.-M. and Hsu, C. and Cheng, A.-L.; Ou, Da-Liang;Chang, Chun-Jung;Jeng, Yung-Ming;Lin, Yi-Jang;Lin, Zhong-Zhe;Gandhi, Anita K.;Liao, Sheng-Chieh;Huang, Zi-Ming;Hsu, Chiun;Cheng, Ann-Lii; 鄭永銘;張純榮;林宗哲;鄭安理;許駿;歐大諒; YUNG-MING JENG; Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; �G�w�z |
| 臺大學術典藏 |
2018-09-10T14:50:09Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, Y.-C. and Li, C.-P. and Yen, C.-J. and Hsu, C. and Lin, Y.-L. and Lin, Z.-Z. and Chen, L.-T. and Su, W.-C. and Chao, Y. and Yeh, K.-H. and Cheng, A.-L.; Shen, Ying-Chun;Li, Chung-Pin;Yen, Chia-Jui;Hsu, Chiun;Lin, Yu-Lin;Lin, Zhong-Zhe;Chen, Li-Tzong;Su, Wu-Chou;Chao, Yee;Yeh, Kun-Huei;Cheng, Ann-Lii; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; KUN-HUEI YEH; Shen, Ying-Chun; Shen, Ying-Chun; Li, Chung-Pin; YU-LIN LIN; Li, Chung-Pin; Yen, Chia-Jui; ANN-LII CHENG; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Yu-Lin; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T14:49:20Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Liang, Ja-Der; Liang, Ja-Der; Tien, Yu-Wen; Tien, Yu-Wen; Hsu, Chiun; Hsu, Chiun; Wong, Jau-Min; Wong, Jau-Min; Chang, Yu-Ting; Chang, Yu-Ting; Chen, Chien-Hung; Chang, M.-C. and Chen, C.-H. and Liang, J.-D. and Tien, Y.-W. and Hsu, C. and Wong, J.-M. and Chang, Y.-T.; Chang, Ming-Chu;Chen, Chien-Hung;Liang, Ja-Der;Tien, Yu-Wen;Hsu, Chiun;Wong, Jau-Min;Chang, Yu-Ting; 翁昭旼;許駿;章明珠;田郁文;陳健弘;張毓廷;梁嘉德; 章明珠; YU-TING CHANG; Chang, Ming-Chu; Chen, Chien-Hung; YU-WEN TIEN |
| 臺大學術典藏 |
2018-09-10T14:49:19Z |
Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan
|
Chang, Y.-T. and Chang, M.-C. and Huang, K.-W. and Tung, C.-C. and Hsu, C. and Wong, J.-M.; Chang, Yu-Ting;Chang, Ming-Chu;Huang, Kai-Wen;Tung, Chien-Chih;Hsu, Chiun;Wong, Jau-Min; Chang, Yu-Ting;Chang, Ming-Chu;Huang, Kai-Wen;Tung, Chien-Chih;Hsu, Chiun;Wong, Jau-Min; 董建志;黃凱文;許駿;章明珠;張毓廷; Chang, Yu-Ting; YU-TING CHANG; Chang, Yu-Ting; KAI-WEN HUANG; Chang, Ming-Chu; Huang, Kai-Wen; Huang, Kai-Wen; Tung, Chien-Chih; Tung, Chien-Chih; Hsu, Chiun; Wong, Jau-Min; Chang, Hao-Hueng |
| 臺大學術典藏 |
2018-09-10T09:38:50Z |
Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients
|
Chen, I. C.;Hsu, C.;Chen, Y. C.;Chien, S. F.;Kao, H. F.;Chang, S. Y.;Hu, F. C.;Yeh, K. H.; Chen, I. C.;Hsu, C.;Chen, Y. C.;Chien, S. F.;Kao, H. F.;Chang, S. Y.;Hu, F. C.;Yeh, K. H.; Chen, I.C. and Hsu, C. and Chen, Y.C. and Chien, S.F. and Kao, H.F. and Chang, S.Y. and Hu, F.C. and Yeh, K.H.; 許駿 ;葉坤輝 ;陳宜君; 許駿 ;葉坤輝 ;陳宜君; Chen, I. C.; Chen, I. C.; HSIANG-FONG KAO; Hsu, C.; Hsu, C.; KUN-HUEI YEH; Chen, Y. C.; Chen, Y. C.; YEE-CHUN CHEN; Chien, S. F.; Kao, H. F.; Chang, S. Y.; Hu, F. C.; Hu, F. C.; Yeh, K. H. |
| 臺大學術典藏 |
2018-09-10T09:16:02Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu, Chiun;Shen, Ying-Chun;Cheng, Chia-Chi;Cheng, Ann-Lii;Hu, Fu-Chang;Yeh, Kun-Huei; Hsu, C. and Shen, Y.-C. and Cheng, C.-C. and Cheng, A.-L. and Hu, F.-C. and Yeh, K.-H.; 鄭安理 ;許駿 ;葉坤輝; Hsu, Chiun; KUN-HUEI YEH; Hsu, Chiun; Shen, Ying-Chun; ANN-LII CHENG; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Hu, Fu-Chang; Yeh, Kun-Huei; Yeh, Kun-Huei |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T07:19:44Z |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, Y.-C. and Hu, F.-C. and Jeng, Y.-M. and Chang, Y.-T. and Lin, Z.-Z. and Chang, M.-C. and Hsu, C. and Cheng, A.-L.; 沈盈君;胡賦強;鄭永銘;張毓廷;林宗哲;章明珠;許駿;鄭安理; SHEN, YING-CHUN;HU, FU-CHANG;JENG, YUNG-MING;CHANG, YU-TING;LIN, ZONG-ZHE;CHANG, MING-CHU;HSU, CHIUN;CHENG, ANN-LII; YUNG-MING JENG; YU-TING CHANG; ANN-LII CHENG; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2016 |
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
|
Hsu, Chiun; Lin, Liang-In; Cheng, Yu-Che; Feng, Zi-Rui; Shao, Yu-Yun; Cheng, Ann-Lii; Ou, Da-Liang; 邵幼雲; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, Shih-Hung; Kuo, Ting-Chun; Wu, Hsu; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chih-Hung; Tien, Yu-Wen; Yeh, Kun-Huei; Cheng, Ann-Lii; Kuo, Sung-Hsin; 郭頌鑫; 鄭安理; 徐志宏; 許駿; 葉坤輝; 郭哲銓; 田郁文; 郭庭均; 楊士弘 |
| 國立臺灣大學 |
2016 |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang, Nai-Jung; Hsu, Chiun; Chen, Jen-Shi; Tsou, Hsiao-Hui; Shen, Ying-Ying; Chao, Yee; Chen, Ming-Huang; Yeh, Ta-Sen; Shan, Yan-Shen; Huang, Shiu-Feng; Chen, Li-Tzong; 許駿 |
| 國立臺灣大學 |
2016 |
Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Liang, Po-Chin; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shih, Tiffany Ting-Fang; 許昭禹; 鄭安理; 陳邦斌; 徐志宏; 許駿; 梁博欽; 游治維 |
| 國立臺灣大學 |
2016 |
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
|
Lu, Li-Chun; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2016 |
Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study
|
Melero, I.; Sangro, B.; Yau, T.; Hsu, C.; Kudo, M.; Crocenzi, T.; Kim, T-Y.; Choo, S-P.; Trojan, J.; Meyer, T.; Welling, T. H., III; Yeo, W.; Chopra, A.; Anderson, J.; Dela Cruz, C.; Lang, L.; Neely, J.; El-Khoueiry, A.; 許駿 |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 國立臺灣大學 |
2015 |
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Ou, Da-Liang; Shyue, Song-Kun; Lin, Liang-In; Feng, Zi-Rui; Liou, Jun-Yang; Fan, Hsiang-Hsuan; Lee, Bin-Shyun; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2015 |
LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION
|
Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 許駿; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu-Yun; Hsu, Chiun; Cheng, Wen-Fan; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 郭漢岳; 郭弘揚; 鄭文芳; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 許駿 |
| 國立臺灣大學 |
2015 |
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)
|
Hsu, Chiun; Chen, Bang-Bin; Chen, Chien-Hung; Ho, Ming-Chih; Cheng, Jason Chia-Hsien; Kokudo, Norihiro; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Jia, Ji-Dong; Han, Kwan-Hyub; Cheng, Ann-Lii; 鄭安理; 成佳憲; 陳邦斌; 許駿; 陳健弘; 何明志 |
| 國立臺灣大學 |
2014 |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo, S-H; Yeh, K-H; Chen, L-T; Lin, C-W; Hsu, P-N; Hsu, C.; Wu, M-S; Tzeng, Y-S; Tsai, H-J; Wang, H-P; Cheng, A-L; 林中梧; 郭頌鑫; 鄭安理; 許駿; 葉坤輝; 王秀伯; 吳明賢; 許秉寧 |
| 國立臺灣大學 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Vertical blockade of the IGFR-PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
|
Ou, Da-Liang; Lee, Bin-Shyun; Lin, Liang-In; Liou, Jun-Yang; Liao, Sheng-Chieh; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 許駿; 歐大諒 |
显示项目 1-25 / 145 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
|
